Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial.
J Immunother Cancer
; 9(12)2021 12.
Article
in En
| MEDLINE
| ID: mdl-34893524
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Platinum
/
Adenoviridae
/
Paclitaxel
/
Drug Resistance, Neoplasm
/
Carcinoma, Ovarian Epithelial
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Immunother Cancer
Year:
2021
Type:
Article
Affiliation country:
Spain